My GP / dentist mentioned lichen planus — what does that mean?

Read this first

A diagnosis of oral lichen planus often comes as a surprise. The terminology can be alarming, the condition can be unfamiliar to your general dentist, and the discussion of malignant transformation risk is uncomfortable. The honest position: most patients with OLP do well with specialist management and ongoing surveillance. The condition is chronic but not in itself dangerous in most cases. The reason for specialist involvement is to monitor the small minority that warrant closer attention.

This article is general educational content. The specific management plan for your case depends on the type and extent of your OLP and your overall health.

What oral lichen planus is

Oral lichen planus (OLP) is a chronic inflammatory condition affecting the mucous membranes of the mouth. It is the oral counterpart of lichen planus on the skin (cutaneous lichen planus); some patients have both, many have only the oral form.

Oral lichen planus is a chronic, immune-mediated inflammatory disease of the oral mucosa that the World Health Organization recognises as a potentially malignant disorder — meaning it carries a small, ongoing risk of malignant change that warrants surveillance (WHO Collaborating Centre for Oral Cancer consensus, 2021).^{4 1} A systematic review and meta-analysis estimated worldwide prevalence at approximately 1% of adults, though estimates vary by population (Gonzalez-Moles et al., 2021).²

What it looks like

OLP has several recognised clinical patterns. A single patient often shows more than one pattern at different sites.

Reticular

The most common presentation. Lacy white striations (Wickham's striae) on the cheek lining, often bilateral. The patches typically do not cause pain or any symptoms — they are often noticed by a dentist at a routine check-up. The patient may have no symptoms at all.

Plaque-like

White patches that look more solid and less lacy than the reticular pattern. Can resemble leukoplakia clinically; specialist evaluation distinguishes between the two.

Atrophic

Red, sensitive patches. The patient typically reports burning sensitivity, especially when eating spicy, acidic, or hot foods.

Erosive

Painful, ulcerated areas — sometimes the most disruptive form for quality of life. Can be persistent or come and go.

Bullous

Less common. Blisters that rupture to leave erosions.

The most important clinical distinction is between reticular OLP (often asymptomatic, conservative management) and erosive / atrophic OLP (symptomatic, more active treatment, more regular surveillance).

What causes it

The cause of OLP is not fully understood. The current model is that it is a T-cell-mediated immune response against the basal cells of the mucosa — the patient's own immune system targets cells in the lining of the mouth, producing the chronic inflammation that the lesions reflect.

Several factors are recognised as contributing or triggering:

• Genetic susceptibility — a family history is not common but exists.
• Medication-induced lichenoid reactions — some medications (NSAIDs, ACE inhibitors, beta-blockers, some antimalarials) can produce OLP-like lesions that improve when the medication is stopped or changed.
• Dental material contact reactions — some patients have lichenoid reactions to amalgam restorations adjacent to the lesion. The lesion sometimes improves when the restoration is replaced with a different material.
• Hepatitis C — an association exists in some populations; screening is considered in selected cases.
• Stress — many patients note that flares coincide with periods of stress.

In a substantial proportion of patients, no specific trigger is identified, and the condition is managed as idiopathic.

How it is diagnosed

Diagnosis is made by:

1. Clinical examination. The clinical appearance is often characteristic, particularly for the reticular form.
2. Biopsy. Histopathological confirmation is standard for non-reticular forms and for any case where the clinical features are not clearly characteristic. The biopsy is taken under local anaesthetic and examined by an oral pathologist.
3. Sometimes additional tests — blood tests via the patient's GP if a contributing medical cause is suspected; allergy patch testing in suspected dental-material reactions.

The biopsy serves two purposes: confirming the diagnosis, and assessing for any dysplastic (pre-malignant) change. The latter is important because of the malignant transformation question discussed below.

How it is managed

Treatment depends on the type and symptoms:

• Asymptomatic reticular OLP: usually no active treatment. Surveillance with periodic specialist review.
• Symptomatic atrophic or erosive OLP:
  • Topical corticosteroids are the first-line treatment for symptomatic OLP. A Cochrane review found that topical corticosteroids may reduce the pain of symptomatic OLP compared with placebo, on low-certainty evidence, and are used for symptom control rather than to clear the lesion or cure the condition (Lodi et al., Cochrane, 2020).⁵ Several preparations exist (gels, mouthwashes, ointments); the right one depends on the site and extent.
  • Topical calcineurin inhibitors (tacrolimus, pimecrolimus) for refractory cases.
  • Systemic corticosteroids for severe flares not controlled by topical treatment.
  • Systemic immunomodulators (hydroxychloroquine, methotrexate, others) for refractory or severe cases, usually in collaboration with a dermatologist or physician.
  • Identifying and modifying triggers — stopping a causative medication, replacing a contact-reaction-causing restoration.
• Symptom-management measures: avoiding spicy or acidic foods during flares, soft-bristled toothbrush, SLS-free toothpaste, alcohol-free mouthwash.

The honest framing: OLP is usually managed long-term, not cured. Most patients achieve good symptom control with topical treatment as needed and periods of remission. A minority have a more chronic course requiring more involved management.

What about the cancer risk

This is the part of the OLP conversation that patients find hardest. The honest evidence:

• OLP is recognised by the WHO as a potentially malignant disorder of the oral mucosa (WHO Collaborating Centre for Oral Cancer consensus, 2021).^{4 1}
• Reported malignant-transformation rates vary with study quality and how strictly the diagnosis is defined, ranging from under 0.5% in analyses using the strictest diagnostic criteria to roughly 2–3% in the most widely cited reviews. A frequently cited meta-analysis reported a pooled rate of about 2.3% (95% CI 1.5–3.2) (Gonzalez-Moles et al., Oral Oncology, 2019).³ The risk is small but not zero, which is the reason surveillance is recommended.
• Erosive and atrophic OLP appear to carry a higher transformation risk than reticular OLP, as do lesions on the tongue and OLP in people who smoke or drink alcohol.
• The risk is concentrated in certain sites — particularly the lateral border of the tongue — and is higher in patients who smoke and consume alcohol.
• Specialist surveillance at appropriate intervals is the standard-of-care response to OLP, because early detection of any malignant change materially changes outcomes.

The pragmatic framing for a patient: the risk is low but non-zero, the surveillance is straightforward (a check-up every 6 to 12 months), and the surveillance is what makes the condition safe to live with. Patients who skip surveillance are accepting a small risk they need not accept.

What you can do

Three practical actions:

1. Engage with the surveillance schedule your specialist recommends. Reticular OLP may need yearly review; symptomatic OLP often needs 4–6 monthly review.
2. Stop smoking if you smoke. The malignant transformation risk concentrates in smokers and alcohol users; the actionable variable is yours.
3. Photograph any new or changing lesion in the mouth between visits and either bring the photo to your next visit or book an interim appointment if the change is significant.

This article is general educational content. The specific surveillance and management plan for your case is determined by a clinical examination by a registered specialist.